Navigation Links
Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 2013
Date:9/30/2013

est of any cancer. In 2013, it is estimated that almost 45,000 new cases of pancreatic cancer will be diagnosed. About one-in-78 people in the U.S. will develop the disease, affecting equal numbers of men and women, almost always after the age of 45. Its tendency to spread prior to diagnosis makes it the fourth deadliest cancer with a less than six percent five-year relative survival rate, with more than 38,000 people succumbing to the disease each year.2-3

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the possible activity, benefits and attributes of PEGPH20, the possible method of action of PEGPH20 and its application in a new potential paradigm for treatment of pancreatic cancer, future clinical trials for PEGPH20, the development of the HA diagnostic tool and its potential uses, and the possible utility of PEGPH20 in pancreatic cancer and other tumors. The forward-looking s
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche
2. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
3. Halozyme to Present New Data on PEGPH20 in Pancreatic Cancer at European Cancer Congress
4. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
5. Halozyme Reports Second Quarter 2013 Financial Results
6. Halozyme Provides Update on ViroPharma Phase 2 Trial of Subcutaneous Cinryze (C1 Esterase Inhibitor [Human]) Formulation with rHuPH20
7. Halozyme to Host Second Quarter 2013 Financial Results Conference Call
8. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
9. Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
10. Halozyme Reports First Quarter 2013 Financial Results
11. Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  World-renowned prostate surgeon and New York Urologist, Dr. ... MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive prostate ... at Lenox Hill Hospital is the only center using ... New York City . We,ve seen tremendous improvement in ... use of an MRI makes for a much more accurate ...
(Date:5/28/2015)... and HOUSTON , May 28, ... (TSX-V: EPI) today reported financial results for the second quarter ... unless specified otherwise, are expressed in Canadian dollars and in ... Summary Results ESSA recorded a net loss ... months ended March 31, 2015 (Q2-2015), compared to a net ...
(Date:5/28/2015)... N.Y. , May 28, 2015 ... the world,s largest provider of health care products ... medical practitioners, today reminded its customers that the ... dentists, physicians and veterinarians who experience operational, logistical ... disastrous storms in the South Central region of ...
Breaking Medicine Technology:MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3
... NicOx S.A.,(Euronext Paris: COX) today announced it ... (OA) patients with controlled hypertension,in two clinical ... line with,previously announced timelines. These trials are ... naproxcinod, in comparison to ibuprofen and,naproxen, using ...
... Ari Kiev, M.D., president of SPRI,Clinical Trials, will be ... The Trout Group Investor Seminar -- Management,s Guide to,Wall ... 30, at Midtown,Loft & Terrace, 267 Fifth Avenue in ... at private and small and mid-cap life science companies ...
Cached Medicine Technology:NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3
(Date:5/29/2015)... Mediaplanet has joined forces with Raw ... the importance of proper sun protection. The print component ... a circulation of approximately 250,000 copies and an estimated ... nationally, through a vast social media strategy, and across ... To explore the digital version of the campaign, ...
(Date:5/29/2015)... 29, 2015 OncLive proudly announces the ... medical pioneers recognized by a panel of eminent oncologists ... cancer treatment. Honorees will be introduced and celebrated TONIGHT ... Ceremony, held 8:30-11:00 p.m. CDT at The Chicago Illuminating ... are being recognized for groundbreaking accomplishments, in fields including ...
(Date:5/29/2015)... 2015 The report “Muscle Spasm ... on the therapeutic development for Muscle Spasm. Spasms ... the body, leading to many different symptoms and ... new targets and MOAs to produce first-in-class and ... review of Axillary Hyperhidrosis with 19 market data ...
(Date:5/29/2015)... 29, 2015 Dr. Rodger Murphree, ... Fatigue Syndrome is now offering free weekly call ... about natural ways to reduce symptoms associated with ... sleep, and brain fog. , To find ... Beating Fibromyalgia call in teleconferences simply go to ...
(Date:5/29/2015)... Healthpointe clinics throughout Southern California are now ... their licensed clinical psychologist, Dr. Levon Margolin. Despite ... an extensive array of physical, cognitive, emotional, and behavioral ... time after a traumatic ordeal involving the brain. Traumatic ... jolt to the head that impedes the normal function ...
Breaking Medicine News(10 mins):Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Healthpointe’s Los Angeles County Clinics Are Now Offering Treatment for Mild Traumatic Brain Injuries 2
... World,s Largest AIDS Fundraising Event Attracts 45,000 Participants and ... Raises Record Sum., Results Defy Economic Downturn and Remind Policy ... ... Walk,New York, on Sunday May 18, was the largest and most successful AIDS Walk,ever held, ...
... avoids incisions, shortens recoveries , , SUNDAY, May 18 ... lead to painless and scar-free surgery with recovery ... surgery, U.S. studies suggest. , Called natural ... inserted through a natural body opening, rather than ...
... ERs sicker than women, more likely to die within a ... into emergency departments with pneumonia are likely to be sicker ... risk of dying within a year, despite receiving more aggressive ... on research from the University of Pittsburgh, were scheduled to ...
... May 18, 2008 Researchers at Washington University School ... type of immune response that is activated in patients ... Their discovery could dramatically improve diagnosis and treatment of ... first part of the molecular code that links a ...
... One ... Family, Disease Hard to ... Work; No Studies on Long-Term Effects in Children, NEW YORK, May 18 ... Up Bipolar" (on newsstands,Monday, May 19), childhood bipolar disorder is hard to pin ...
... ATS 2008, TORONTOWomen who are stressed during pregnancy may ... the form of increased sensitivity to allergen exposure and ... Medical School who will present their findings at the ... Sunday, May 18. , While predisposition to asthma ...
Cached Medicine News:Health News:AIDS Walk New York Raises $7.05 Million 2Health News:New Surgical Technology Holds Promise of Painless, Scarless Procedures 2Health News:New Surgical Technology Holds Promise of Painless, Scarless Procedures 3Health News:Study Finds Gender Disparity in Community-Acquired Pneumonia 2Health News:Personalized therapy for asthma and COPD could soon be here 2Health News:Personalized therapy for asthma and COPD could soon be here 3Health News:Personalized therapy for asthma and COPD could soon be here 4Health News:NEWSWEEK Cover: Growing Up Bipolar 2Health News:NEWSWEEK Cover: Growing Up Bipolar 3Health News:Mother's prenatal stress predisposes their babies to asthma and allergy 2
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... a low implant profile, 0.84mm, for better ... insertion is technically simpler and allows a ... installed with less trauma than multiple quadrant ... implant were designed to minimize bleb height ...
1-Meter Roll-Up Tangent Screen....
... accurate detections of any ... as glaucoma in the ... performed. Smooth operation of ... High accuracy of static ...
Medicine Products: